Free tool
Oncology stocks
We cover 19 companies grouped under the Oncology theme. The median market value in the group is $671.98M. Across the group, the median move over the past trading day is 0.00%. Price change over the past year runs from −54.2% to +353.2% across the middle 80 percent of the group, with a median of +9.2%.
Other lists in this group
SaaSAI applicationsCybersecuritySemiconductor designSemiconductor equipmentFintech softwarePayment processingEcommerce marketplacesStreaming mediaGaming softwareOncologyRare diseaseMedical devicesCell therapyDiagnosticsRegional banksAsset managementGold miningCryptocurrency and digital assetsSpecialty chemicalsAll stocks
Table
19 of 319 companies match these filters.Clear filters
| Ticker | Company | Price | 1M return | YTD return | 1Y return | Next report |
|---|---|---|---|---|---|---|
| 4519.T | Chugai Pharmaceutical Co., Ltd. | 6,953.00 JPY | −1.64% | −18.35% | +9.21% | Oct 27, 2026 |
| INCY | Incyte Corporation | $128.12 | −1.39% | +26.33% | +51.01% | Oct 27, 2026 |
| EXEL | Exelixis, Inc. | $56.10 | −0.73% | +28.73% | +45.68% | Oct 27, 2026 |
| 0IJO.L | Exelixis, Inc. | $56.81 | +4.53% | +31.50% | +50.53% | Oct 27, 2026 |
| SMMT | Summit Therapeutics Inc. | $14.23 | +13.39% | −18.78% | −42.63% | Oct 19, 2026 |
| RCUS | Arcus Biosciences, Inc. | $30.76 | +13.72% | +32.07% | +191.29% | Oct 27, 2026 |
| NRIX | Nurix Therapeutics, Inc. | $26.71 | +10.60% | +47.90% | +179.69% | Oct 8, 2026 |
| NBTX | Nanobiotix S.A. | $44.50 | +17.66% | +101.08% | +394.99% | Sep 29, 2026 |
| NANO.PA | Nanobiotix S.A. | 35.74 EUR | +8.43% | +88.11% | +358.21% | Sep 29, 2026 |
| 0QAV.L | Nanobiotix S.A. | 35.02 EUR | −1.38% | +82.87% | +351.98% | Sep 29, 2026 |
| IPHA | Innate Pharma S.A. | $2.16 | +28.57% | +18.68% | +2.86% | Sep 17, 2026 |
| IDD.DE | Innate Pharma S.A. | 1.78 EUR | +12.80% | +12.80% | −2.52% | Sep 17, 2026 |
| IPH.PA | Innate Pharma S.A. | 1.88 EUR | +19.01% | +16.21% | +1.19% | Sep 17, 2026 |
| ANIX | Anixa Biosciences, Inc. | $3.61 | +2.41% | +14.08% | +22.20% | Sep 9, 2026 |
| OSE.PA | OSE Immunotherapeutics SA | 3.21 EUR | −0.19% | −39.40% | −47.94% | Sep 28, 2026 |
| IMMP | Immutep Limited | $0.38 | −2.56% | −87.12% | −77.11% | Sep 2, 2026 |
| 0RAD.L | OSE Immunotherapeutics SA | 3.19 EUR | −1.30% | −39.91% | −48.50% | Sep 28, 2026 |
| BLRX | BioLineRx Ltd. | $2.70 | −3.91% | −3.57% | −26.63% | Aug 31, 2026 |
| LNAI | Lunai Bioworks Inc. | $2.20 | −1.79% | −71.71% | −89.34% | Sep 28, 2026 |
Covers ~22,000 companies across the US, Europe and Asia-Pacific (ex mainland China, Hong Kong and India), refreshed nightly. Every listed stock opens as a full analysis for $9.90.